Rare diseases
Investigational molecules
Locations
Back to Greece1 008 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
GreeceStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
GreeceStudy of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes
GreeceStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
GreeceStudy of Belzutifan for Patients with Advanced Kidney Cancer
GreeceStudy on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)
GreeceStudy of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms
GreeceStudy Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions
GreeceStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
GreeceStudy on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers
GreeceStudy on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
GreeceStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
